Hyaluronidase for Stroke-Related Shoulder Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether hyaluronidase, an enzyme treatment, can reduce shoulder pain in individuals who have experienced a stroke. Shoulder pain after a stroke is common and can hinder movement, impacting quality of life. Researchers are examining two groups: one receives hyaluronidase with saline, while the other receives only saline. Individuals who have had a stroke and experience difficulty moving their shoulder, with or without pain, may be suitable candidates for this trial. As a Phase 2 trial, the research focuses on assessing the treatment's effectiveness in an initial, smaller group of participants.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you have had certain treatments for spasticity recently or are adjusting anti-spastic medications.
Is there any evidence suggesting that hyaluronidase is likely to be safe for humans?
A previous study found that injections of hyaluronidase for shoulder pain after a stroke were safe, with no serious side effects reported. This treatment is considered safer than other options, such as corticosteroid injections. Research has also shown that hyaluronic acid can help relieve pain and improve shoulder movement in stroke patients. Evidence so far suggests that hyaluronidase is well-tolerated, making it a promising option for managing shoulder pain after a stroke.12345
Why do researchers think this study treatment might be promising for stroke-related shoulder pain?
Most treatments for stroke-related shoulder pain, like physical therapy and medications such as NSAIDs or corticosteroids, focus on reducing inflammation and improving mobility over time. However, hyaluronidase is unique because it breaks down hyaluronic acid, a component that can contribute to tissue stiffness and pain. This mechanism potentially offers quicker relief by enhancing tissue permeability and reducing pressure in the affected area. Researchers are excited about hyaluronidase because it could offer a new, faster-acting option for managing shoulder pain after a stroke, which is a significant improvement over conventional treatments.
What evidence suggests that hyaluronidase might be an effective treatment for post-stroke shoulder pain?
This trial will compare the effects of hyaluronidase plus saline with a saline injection alone for stroke-related shoulder pain. Research has shown that hyaluronic acid, related to the enzyme hyaluronidase, can reduce shoulder pain and improve movement in stroke patients. Studies have found that injecting hyaluronic acid can lead to less pain and better shoulder movement in individuals with paralysis on one side of their body after a stroke. This treatment addresses issues with the tissues around muscles, which can cause pain. By breaking down excess hyaluronic acid that accumulates in the muscles, hyaluronidase may improve muscle movement and reduce pain. Although more research is needed, these findings suggest that hyaluronidase could provide relief for those suffering from shoulder pain after a stroke.12678
Who Is on the Research Team?
Ning Cao, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for adults over 18 who have had a stroke between 3 to 180 months ago, leading to hemiparesis (weakness on one side of the body). They must be able to consent and follow study rules. Eligible participants show at least a 10-degree difference in shoulder movement range between their affected and unaffected sides, with or without pain.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive hyaluronidase or saline injections to treat post-stroke shoulder pain
Follow-up
Participants are monitored for changes in T1ρ relaxation times, pain, range of motion, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- hyaluronidase
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator